Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

Trial Profile

Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

Suspended
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2017

At a glance

  • Drugs Risperidone (Primary)
  • Indications Bipolar disorders; Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jul 2017 Status changed from recruiting to suspended.
    • 16 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2019, according to to ClinicalTrials.gov record
    • 16 Apr 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2019, according to to ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top